Equities Research Analysts’ Updated EPS Estimates for March 24th (AARD, AEM, AKZOY, AVTX, BLDR, BOOT, CMPX, CNTX, EVPL, EXAS)

Equities Research Analysts’ updated eps estimates for Tuesday, March 24th:

Aardvark Therapeutics (NASDAQ:AARD) had its buy rating reaffirmed by analysts at BTIG Research. The firm currently has a $9.00 price target on the stock.

Agnico Eagle Mines (NYSE:AEM) (TSE:AEM) was downgraded by analysts at Erste Group Bank AG from a buy rating to a hold rating.

Akzo Nobel (OTCMKTS:AKZOY) was downgraded by analysts at Deutsche Bank Aktiengesellschaft from a buy rating to a hold rating.

Avalo Therapeutics (NASDAQ:AVTX) had its buy rating reissued by analysts at BTIG Research. The firm currently has a $40.00 price target on the stock.

Builders FirstSource (NYSE:BLDR) had its equal weight rating reaffirmed by analysts at Stephens. They currently have a $125.00 price target on the stock.

Henry Boot (LON:BOOT) had its buy rating reaffirmed by analysts at Berenberg Bank. They currently have a GBX 326 price target on the stock.

Compass Therapeutics (NASDAQ:CMPX) had its buy rating reiterated by analysts at Guggenheim. The firm currently has a $12.00 target price on the stock.

Context Therapeutics (NASDAQ:CNTX) had its buy rating reaffirmed by analysts at Guggenheim. They currently have a $5.00 price target on the stock.

Everplay Group (LON:EVPL) had its buy rating reiterated by analysts at Shore Capital Group Ltd.

Exact Sciences (NASDAQ:EXAS) had its neutral rating reaffirmed by analysts at BTIG Research.

Flowtech Fluidpower (LON:FLO) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a GBX 100 target price on the stock.

Gamma Communications (LON:GAMA) had its buy rating reissued by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 1,570 target price on the stock.

Hillman Solutions (NASDAQ:HLMN) had its buy rating reissued by analysts at Canaccord Genuity Group Inc.. The firm currently has a $14.00 target price on the stock.

J.Jill (NYSE:JILL) had its market perform rating reaffirmed by analysts at Telsey Advisory Group. Telsey Advisory Group currently has a $16.00 target price on the stock.

Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $9.00 price target on the stock.

Moleculin Biotech (NASDAQ:MBRX) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $22.00 target price on the stock.

M.P. Evans Group (LON:MPE) had its buy rating reissued by analysts at Canaccord Genuity Group Inc.. The firm currently has a GBX 1,750 target price on the stock.

Nurix Therapeutics (NASDAQ:NRIX) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $32.00 price target on the stock.

NRx Pharmaceuticals (NASDAQ:NRXP) had its buy rating reissued by analysts at BTIG Research. BTIG Research currently has a $25.00 target price on the stock.

Procter & Gamble (NYSE:PG) was downgraded by analysts at Erste Group Bank AG from a buy rating to a hold rating.

Pharming Group (NASDAQ:PHAR) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $37.00 target price on the stock.

PPHC (NASDAQ:PPHC) had its buy rating reissued by analysts at Canaccord Genuity Group Inc.. They currently have a $18.00 target price on the stock.

Pyxis Oncology (NASDAQ:PYXS) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $7.00 target price on the stock.

Ultragenyx Pharmaceutical (NASDAQ:RARE) was downgraded by analysts at The Goldman Sachs Group, Inc. from a buy rating to a neutral rating. The firm currently has $25.00 target price on the stock.

SAP (NYSE:SAP) had its neutral rating reiterated by analysts at JPMorgan Chase & Co..

Shawbrook Group (LON:SHAW) had its buy rating reissued by analysts at Shore Capital Group Ltd.

Sky Harbour Group (NYSE:SKYH) had its buy rating reiterated by analysts at BTIG Research. BTIG Research currently has a $13.00 target price on the stock.

Surrozen (NASDAQ:SRZN) had its overweight rating reissued by analysts at Cantor Fitzgerald. The firm currently has a $40.00 target price on the stock.

Surrozen (NASDAQ:SRZN) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $36.00 target price on the stock, up from their previous target price of $32.00.

Strategic Education (NASDAQ:STRA) was downgraded by analysts at Truist Financial Corporation from a buy rating to a hold rating. They currently have $85.00 target price on the stock.

TransAlta (NYSE:TAC) (TSE:TA) had its outperform rating reissued by analysts at Royal Bank Of Canada. They currently have a $24.00 target price on the stock.

The Mission Group (LON:TMG) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. The firm currently has a GBX 55 target price on the stock.

Tapestry (NYSE:TPR) was downgraded by analysts at Wall Street Zen from a strong-buy rating to a buy rating.

Ultimate Products (LON:ULTP) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. The firm currently has a GBX 80 price target on the stock.

Xaar (LON:XAR) had its buy rating reiterated by analysts at Berenberg Bank. The firm currently has a GBX 140 price target on the stock.

Xencor (NASDAQ:XNCR) had its neutral rating reaffirmed by analysts at JPMorgan Chase & Co.. They currently have a $13.00 target price on the stock, down from their previous target price of $18.00.